Quality Care - everyone, everytime
 

8.2 Drugs Affecting the Immune Response

Chemotherapy drugs are frequently given in combination.

Disease specific protocols are approved at local and network level.

Only approved protocols should be used. All chemotherapy treatment decisions should be made by a consultant grade oncologist or haematologist, with input from the relevant multidisciplinary team.

Chemotherapy drugs, including oral therapies must be prescribed, dispensed and administered only by suitable trained staff.

Paediatric cancer therapies are initiated and prescribed from tertiary cancer centres. The exception is maintenance treatment for some cancers, which is prescribed by designated paediatricians only.

 8.2.1 Antiproliferative immunosuppressants

   AZATHIOPRINE (Amber)
   

  8.2.2 Corticosteroids and other immunosuppressants

   CICLOSPORIN (Amber) Specific brand of ciclosporin to be continued in transplant patients
   

  8.2.3 Anti-lymphocyte monoclonal antibodies

   RITUXIMAB
   

 8.2.4 Other immunomodulating drugs 

   TERIFLUNOMIDE
   INTERFERON alpha and beta
   THALIDOMIDE (Pharmion)
   LENALIDOMIDE

 

Related pages

Keep up to date with the latest Trust News

Our Performance

To see our latest performance and financial report click here.

Tell Us Your Views

Click here to find out how you can feedback to us about your experiences, along with how to raise any concerns, complaints or questions.